SIGNET GROUP PLC
SC 13D/A, 1999-04-08
JEWELRY STORES
Previous: AMSOUTH MUTUAL FUNDS, N-30D, 1999-04-08
Next: MERITAGE CORP, DEF 14A, 1999-04-08







UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C.  20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934
(Amendment No. 2)

SIGNET GROUP PLC
(Name of Issuer)

ORDINARY SHARES OF 0.5p
(Title of Class of Securities)

82668L104
(CUSIP Number)

Fred M. Stone, Senior Vice President and General Counsel
M.D. Sass Investors Services, Inc.
1185 Avenue of the Americas, 18th Floor, New York, NY 10036
Telephone  212-730-2000
(Name, Address and Telephone Number of Person Authorized to Receive Notices  and
Communications)

April 1, 1999
(Date of Event which Requires Filing of this Statement)

If  the filing person has previously filed a statement on Schedule 13G to report
the  acquisition that is the subject of this Schedule 13D, and  is  filing  this
schedule  because  of Rule 13d-1(e), Rule 13d-1(f) or Rule 13d-1(g),  check  the
following box.[ ]

Note:  Schedules filed in paper format shall include a signed original and  five
copies  of  the  schedule, including all exhibits. See Rule 13d-7(b)  for  other
parties to whom copies are to be sent.

*The  remainder of this cover page shall be filled out for a reporting  person's
initial filing on this form with respect to the subject class of securities, and
for   any   subsequent  amendment  containing  information  which  would   alter
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to  be  "filed" for the purpose of Section 18 of the Securities Exchange Act  of
1934 ("Act") or otherwise subject to the liabilities of that section of the  Act
but  shall  be  subject  to all other provisions of the Act  (however,  see  the
Notes).

<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     Martin D. Sass

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X          (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     United States

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     57,146,126

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     57,146,126 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     57,146,126 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     3.41%

14   TYPE OF REPORTING PERSON*

     IN


<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     James B. Rubin

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X          (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     United States

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER
     59,044,430

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     59,044,430 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     59,044,430 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     3.53%

14   TYPE OF REPORTING PERSON*

     IN


<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     M.D. Sass Associates, Inc.

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X          (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     13,946,739

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     13,946,739 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     13,946,739 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.83%

14   TYPE OF REPORTING PERSON*

     IA, CO


<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     M.D. Sass Investors Services, Inc.

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X          (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     47,825,610

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     47,825,610 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     47,825,610 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     2.86%

14   TYPE OF REPORTING PERSON*

IA, CO

<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     M.D. Sass Re/Enterprise Partners, L.P.

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X          (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     11,210,588

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     11,210,588 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     11,210,588 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     .67%

14   TYPE OF REPORTING PERSON*

     PN


<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     M.D. Sass Re/Enterprise-II, L.P.

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X     (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     Delaware

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     2,736,151

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     2,736,151 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     2,736,151 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.16%

14   TYPE OF REPORTING PERSON*

     PN


<PAGE>

SCHEDULE 13D
CUSIP No. 82668L104

1    NAME OF REPORTING PERSON
     S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON

     M.D. Sass Associates, Inc. Employee Profit Sharing Plan

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP  (a) X           (b)


3    SEC USE ONLY

4    SOURCE OF FUNDS

     00

5     CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION

     New York

     NUMBER OF SHARES BENEFICIALLY OWNED BY EACH  REPORTING PERSON WITH:

7    SOLE VOTING POWER

     None

8    SHARED VOTING POWER

     538,926

9    SOLE DISPOSITIVE POWER

     None

10   SHARED DISPOSITIVE POWER

     538,926 (See Items 2, 4 and 5)

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON

     538,926 (See Items 5 and 6)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)

     0.03%

14   TYPE OF REPORTING PERSON*

     EP


<PAGE>

Item 1.   Security and Issuer

      This Amendment No. 2 amends the Schedule 13D filed on August 11, 1997 (the
"Schedule  13D  Report") by Martin D. Sass ("Sass"); James B.  Rubin  ("Rubin");
M.D.  Sass  Associates, Inc., a Delaware corporation ("Associates");  M.D.  Sass
Investors  Services,  Inc.,  a  Delaware corporation  ("Investors");  M.D.  Sass
Re/Enterprise  Partners, L.P., a Delaware limited partnership ("Re/Enterprise");
M.D. Sass Re/Enterprise-II, L.P., a Delaware limited partnership ("Re/Enterprise
II");  and  M.D.  Sass  Associates, Inc. Employee Profit Sharing  Plan  ("Profit
Sharing  Plan")  as  the Reporting Persons named therein, and  Amendment  No.  1
thereto, relating to the Ordinary Shares of 0.5p (the "Shares") of Signet  Group
plc,  a  corporation  organized under the laws of England (the  "Issuer").   The
principal executive offices of the Issuer are located at Zenith House, The Hyde,
London NW9, England.


Item 5.   Interest in Securities of the Issuer

     (a) and (d) These items as set forth in the Schedule 13D and Amendment No.
1 are deleted and the following is inserted in its place

(a)   Re/Enterprise  holds 11,210,588 Shares, constituting 0.67%  of  the  total
outstanding Shares.
      Re/Enterprise II holds 2,736,151 Shares, constituting 0.16% of  the  total
outstanding Shares.
        Re/Enterprise  International holds 6,501,454 Shares, constituting  0.39%
        of the total outstanding Shares.
      Profit Sharing Plan holds 538,926 Shares, constituting 0.03% of the  total
outstanding Shares.
      The  ERISA Plans hold 32,704,368 Shares, constituting 1.95% of  the  total
outstanding Shares.
      Corporate  Renaissance holds 1,174,503 Shares, constituting 0.07%  of  the
total outstanding Shares.
       Parallax  holds  2,280,136  Shares,  constituting  0.14%  of  the   total
outstanding Shares.
          Rubin   holds   approximately  1,898,304  Shares   (including   family
          accounts),  constituting  0.11%  of  the  total  outstanding  Ordinary
          Shares.

     Associates, as a general partner of Re/Enterprise and Re/Enterprise II, may
be  deemed  to  beneficially own an aggregate of 13,946,739 Shares, constituting
0.83% of the total outstanding Shares.

      Investors, as a general partner of Re/Enterprise and Re/Enterprise II,  as
investment  manager to Corporate Renaissance, and as investment advisor  to  the
ERISA  Plans,  may  be  deemed to beneficially own an  aggregate  of  47,825,610
Shares, constituting 2.86% of the total outstanding Shares.

      Sass,  by  virtue  of  his controlling interest  in  each  of  Associates,
Investors, Management and GPU, and as trustee of the Profit Sharing Plan, may be
deemed to beneficially own an aggregate of 57,146,126 Shares, constituting 3.41%
of the total outstanding Shares.

      Rubin,  by  virtue  of  his  position as portfolio  manager  to  Parallax,
Re/Enterprise,   Re/Enterprise   II,  Re/Enterprise   International,   Corporate
Renaissance,  the  ERISA Plans, and the Profit Sharing Plan, may  be  deemed  to
beneficially  own 59,044,430 Shares (which includes 1,898,304  Shares  owned  by
family accounts), constituting 3.53% of the total outstanding Shares.


<PAGE>

      This percentage is based on 1,674,842,749 Shares that were outstanding  as
of  August  1,  1998, as reported in the Issuer's Form 6-K for the month  August
1998.   As of April 1, 1999, the Reporting Persons no longer own 5% or  more  of
the Shares, and this Schedule 13D is hereby terminated.

<PAGE>

      (c)   A schedule of each transaction in the Stock by the persons described
above since March 29, 1999, is attached as Exhibit B.


Item 7.   Material to be Filed as Exhibits

Exhibit A Joint Filing Agreement
Exhibit B Schedule of Purchases and Sales

<PAGE>


      After reasonable inquiry and to the best of its knowledge and belief,  the
undersigned certifies that the information set forth in this statement is  true,
complete and correct.

Dated:  April 8, 1999

                              /s/  Martin D. Sass
                              __________________________________
                              Martin D. Sass


                              /s/  James B. Rubin
                              __________________________________
                              James B. Rubin


                              M.D. SASS ASSOCIATES, INC.


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President


                              M.D. SASS INVESTORS SERVICES, INC.


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President


                              M.D. SASS RE/ENTERPRISE PARTNERS, L.P.


                              By:  M.D. Sass Associates, Inc., as
                                   Managing General Partner

                              By: /s/   Fred M. Stone
                              __________________________________
                                   Name:     Fred M. Stone
                                   Title:    Senior Vice President


                              M.D. SASS RE/ENTERPRISE-II, L.P.


                              By:  M.D. Sass Investors, Inc., as
                                   Managing General Partner

                              By: /s/   Fred M. Stone
                              __________________________________
                                   Name:     Fred M. Stone
                                   Title:    Senior Vice President


                              M.D. SASS ASSOCIATES, INC. EMPLOYEE
                              PROFIT SHARING PLAN


                              By: /s/   Martin D. Sass
                              __________________________________
                              Name:     Martin D. Sass
                              Title:    Trustee


<PAGE>

     Exhibit Index

Exhibit A --   Joint Filing Agreement
Exhibit B --   Schedule of Transactions

<PAGE>

     EXHIBIT A

Joint Filing Agreement

     In accordance with Rule 13d-1(f) under the Securities Exchange Act of 1934,
as amended, each of the persons named below agrees to the joint filing on behalf
of  each  of them of a Statement on Schedule 13D (including amendments  thereto)
with  respect to the Ordinary Shares of 0.5p of Signet Group plc, a  corporation
organized  under the laws of England, and further agrees that this Joint  Filing
Agreement  be  included  as  an  exhibit  to  such  filings  provided  that,  as
contemplated by Section 13d-1(f)(l)(ii), no person shall be responsible for  the
completeness or accuracy of the information concerning the other persons  making
the  filing,  unless  such  person knows or has  reason  to  believe  that  such
information  is  inaccurate.  This Agreement may be executed in  any  number  of
counterparts,  all of which taken together shall constitute  one  and  the  same
instrument.

Dated:    July 21, 1997

Signatures



                              /s/  Martin D. Sass
                              __________________________________
                              Martin D. Sass



                              /s/  James B. Rubin
                              __________________________________
                              James B. Rubin



                              M.D. SASS ASSOCIATES, INC.


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President



                              M.D. SASS INVESTORS SERVICES, INC.


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President



                              M.D. SASS RE/ENTERPRISE PARTNERS, L.P.
                              By:       M.D. Sass Associates, Inc., as
                                   Managing General Partner


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President



                              M.D. SASS RE/ENTERPRISE-II, L.P.
                              By:       M.D. Sass Investors Services, Inc., as
                                   Managing General Partner


                              By: /s/   Fred M. Stone
                              __________________________________
                              Name:     Fred M. Stone
                              Title:    Senior Vice President



                              M.D. SASS ASSOCIATES, INC. EMPLOYEE
                              PROFIT SHARING PLAN


                              By: /s/   Martin D. Sass
                              __________________________________
                              Name:     Martin D. Sass
                              Title:    Trustee

<PAGE>

EXHIBIT B

Schedule of Transactions

                               SIGNET ORDINARY 5P
                       TRADING ACTIVITY 3/29/99 to 4/8/99
                   (ALL OF THE FOLLOWING TRADES WERE EXECUTED
                          ON THE LONDON STOCK EXCHANGE)
<TABLE>
                                        
Entity       Type       Trade Date  Price/share
                                      (GBP)         Units
<S>                     <C>         <C>           <C>

CREN         SALE       01-Apr-99   0.4950        (229,643)
CREN         SALE       01-Apr-99   0.4950        (36,225)
CREN         SALE       06-Apr-99   0.5025        (92,629)
                                    Ending Bal    1,174,503

Re/Ent Int'l SALE       01-Apr-99   0.4950        (1,266,088)
Re/Ent Int'l SALE       01-Apr-99   0.4950        (4,965,100)
Re/Ent Int'l SALE       06-Apr-99   0.5025        (617,298)
                                    Ending Bal    6,501,454

Erisa Plan 1 SALE       01-Apr-99   0.4950        (5,593,516)
Erisa Plan 1 SALE       01-Apr-99   0.4950        (10,225,671)
Erisa Plan 1 SALE       06-Apr-99   0.5025        (2,333,681)
                                    Ending Bal    28,802,662

Erisa Plan 2 SALE       01-Apr-99   0.4950        (758,487)
Erisa Plan 2 SALE       01-Apr-99   0.4950        (1,265,750)
Erisa Plan 2 SALE       06-Apr-99   0.5025        (316,057)
                                    Ending Bal    3,901,706

Parallax     SALE       01-Apr-99   0.4950        (443,292)
Parallax     SALE       01-Apr-99   0.4950        (2,695,668)
Parallax     SALE       06-Apr-99   0.5025        (250,250)
                                    Ending Bal    2,280,136

Profit Sharing          SALE        01-Apr-99     0.4950         (105,068)
Profit Sharing          SALE        01-Apr-99     0.4950         (296,571)
Profit Sharing          SALE        06-Apr-99     0.5025         (48,842)
                                    Ending Bal    550,926

Re / Ent     SALE       01-Apr-99   0.4950        (2,194,229)
Re / Ent     SALE       01-Apr-99   0.4950        (2,778,350)
Re / Ent     SALE       06-Apr-99   0.5025        (896,374)
                                    Ending Bal    11,210,588

Rubin - 1    SALE       01-Apr-99   0.4950        (350,178)
Rubin - 1    SALE       01-Apr-99   0.4950        (1,683,045)
Rubin - 1    SALE       06-Apr-99   0.5025        (210,719)
                                    Ending Bal    1,766,710

Rubin - 2    SALE       01-Apr-99   0.4950        (26,083)
Rubin - 2    SALE       01-Apr-99   0.4950        (125,362)
Rubin - 2    SALE       06-Apr-99   0.5025        (15,696)
                                    Ending Bal    131,594

Re / Ent II  SALE       01-Apr-99   0.4950        (533,416)
Re / Ent II  SALE       01-Apr-99   0.4950        (928,258)
Re / Ent II  SALE       06-Apr-99   0.5025        (230,454)
                                    Ending Bal    2,736,151

</TABLE>



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission